newsfilter
← Latest News
GlobeNewswire·

Revive Therapeutics Announces LOI to Acquire DiagnaMed's Molecular Hydrogen Program

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- TORONTO, March 3, 2025 – Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF) (CSE:RVV) (FRANKFURT:31R), a specialty life sciences company focused on the